Physician
Azaz, Mohammed
Azaz, Mohammed was paid $214K by Medicaid between Jan 2018 and Nov 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 70% of everything it billed.
33Billing provider infoAZAZ, MOHAMMED
COMMACK, NY 11725
COMMACK, NY 11725
33aNPI1356331763assigned 10/26/2005
33bProvider typeInternal Medicine Physician
28Total paid$214K
24GClaims14,671
24DCodes billed24
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#826 of 6,049
Median peer was paid$11K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 682 | $12K | |
| 2019 | 2,156 | $17K | |
| 2020 | 2,916 | $37K | |
| 2021 | 2,881 | $43K | |
| 2022 | 2,575 | $42K | |
| 2023 | 2,823 | $45K | |
| 2024incomplete | 638 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 70% | 2,630 | 2,020 | $149K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 26% | 644 | 630 | $56K |
| 36415 | Collection of venous blood by venipuncture | 1.1% | 1,041 | 1,000 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 132 | 128 | $2K |
| 93000 | <1% | 83 | 83 | $986.48 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 103 | 100 | $687.82 |
| 94010 | <1% | 33 | 32 | $607.57 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 144 | 138 | $605.77 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 54 | 53 | $577.08 |
| 81002 | <1% | 236 | 219 | $533.47 | |
| 1111F | <1% | 712 | 578 | $510.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 47 | 46 | $256.61 |
12 more codes
| 96160 | <1% | 28 | $62.36 | |
| 99072 | <1% | 34 | $25.00 | |
| 0516F | 0% | 12 | $0.00 | |
| 99000 | 0% | 34 | $0.00 | |
| 1036F | 0% | 73 | $0.00 | |
| 3008F | 0% | 175 | $0.00 | |
| 3074F | 0% | 38 | $0.00 | |
| 1159F | 0% | 2,579 | $0.00 | |
| 99080 | 0% | 313 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 2,907 | $0.00 |
| 1160F | 0% | 2,585 | $0.00 | |
| 3078F | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.